<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16455">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01679509</url>
  </required_header>
  <id_info>
    <org_study_id>LESS-A</org_study_id>
    <nct_id>NCT01679509</nct_id>
  </id_info>
  <brief_title>Study of Laparoendoscopic Single Site Adnexal Surgery for Benign Ovarian and Tubal Disease</brief_title>
  <official_title>Prospective Randomized Comparison of Single-port and Three-port Laparoscopic Adnexal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <authority>Korea: Asan Medical Center Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the safety and efficacy between single-port and three-port adnexal surgery in
      patients with benign ovarian and tubal disease
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>postoperative hospital stay</measure>
    <time_frame>within 1 week after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>within 1 week after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative analgesics requirement</measure>
    <time_frame>within 1 week after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>within 6 months aftr surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>surgical stress response</measure>
    <time_frame>within 2 days after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>operating time</measure>
    <time_frame>immediately ater surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>transfusion requirement and amount</measure>
    <time_frame>within 1 week after surgery</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complication</measure>
    <time_frame>within 1 months after surgery</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">330</enrollment>
  <condition>Benign Ovarian or Tubal Disease</condition>
  <arm_group>
    <arm_group_label>Single-port surgery group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single-port laparoscopic adnexal surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Three-port surgery group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Three-port laparoscopic adnexal surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Single-port laparoscopic adnexal surgery</intervention_name>
    <arm_group_label>Single-port surgery group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Three-port laparoscopic adnexal surgery</intervention_name>
    <arm_group_label>Three-port surgery group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient who undergo laparoscopic adnexal surgery due to following benign adenxal
             disease

               1. Benign teratoma

               2. Endometrioma

               3. Mucinous cystadenoma

               4. Serous cystadenoma

               5. Benign Brenner tumor

               6. Ectopic pregnancy(cornual, tubal, ovarian pregnancy, etc.)

               7. paratubal cyst, parovarian cyst

               8. Risk reducing bilateral salpingooophorecotmy due to familial breast/ovarian
                  cancer syndrome

               9. Other benign adnexal disease requiring surgery

          -  American Society of Anesthesiologist Physical Status classification I-II.

          -  Patient who have signed written informed consent

        Exclusion Criteria:

          -  Uncontrolled medical disease

          -  Active infectious disease

          -  Previous pelvic radiation therapy

          -  Patient who requires further procedure excluding adnexal surgery

          -  Patient who has other pain source excluding adnexal disease

          -  Pregnant and lactating woman
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joo-Hyun Nam, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joo-Hyun Nam, M.D., Ph.D.</last_name>
    <phone>82-2-3010-3633</phone>
    <email>jhnam@amc.seoul.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology, Universit of Ulsan College of Medicine, Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joo-Hyun Nam, M.D., Ph.D.</last_name>
      <phone>82-2-3010-3633</phone>
      <email>jhnam@amc.seoul.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 3, 2012</lastchanged_date>
  <firstreceived_date>September 3, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Joo-Hyun Nam</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
